CCMINC
GSK icon

Cardinal Capital Management Inc (North Carolina)’s GSK GSK Stock Holding History

Cardinal Capital Management Inc (North Carolina)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Sell
62,101
-69
-0.1% -$3.65K 0.4% 79
2026
Q1 		$3.46M Buy
62,170
+426
+0.7% +$23.1K 0.45% 77
2025
Q4 		$3.05M Buy
61,744
+251
+0.4% +$11.7K 0.4% 78
2025
Q3 		$2.68M Buy
61,493
+1,327
+2% +$51.8K 0.37% 85
2025
Q2 		$2.34M Buy
60,166
+1,594
+3% +$60.9K 0.34% 88
2025
Q1 		$2.29M Buy
58,572
+244
+0.4% +$8.93K 0.36% 87
2024
Q4 		$1.99M Buy
58,328
+1,956
+3% +$70.4K 0.31% 92
2024
Q3 		$2.33M Buy
56,372
+808
+1% +$33.1K 0.36% 85
2024
Q2 		$2.16M Buy
55,564
+1,390
+3% +$58.5K 0.36% 82
2024
Q1 		$2.34M Buy
54,174
+4,332
+9% +$179K 0.38% 81
2023
Q4 		$1.86M Buy
49,842
+226
+0.5% +$8.11K 0.35% 84
2023
Q3 		$1.82M Buy
49,616
+948
+2% +$33.6K 0.37% 82
2023
Q2 		$1.75M Sell
48,668
-26,655
-35% -$956K 0.35% 83
2023
Q1 		$2.69M Buy
75,323
+43,599
+137% +$1.53M 0.56% 58
2022
Q4 		$1.11M Buy
31,724
+1,112
+4% +$37K 0.24% 105
2022
Q3 		$901K Sell
30,612
-1,370
-4% -$51.9K 0.21% 107
2022
Q2 		$1.74M Buy
31,982
+265
+0.8% +$14.6K 0.4% 72
2022
Q1 		$1.73M Buy
31,717
+1,273
+4% +$69.1K 0.35% 84
2021
Q4 		$1.68M Sell
30,444
-27
-0.1% -$1.41K 0.33% 86
2021
Q3 		$1.46M Sell
30,471
-8,123
-21% -$408K 0.32% 87
2021
Q2 		$1.92M Buy
38,594
+19,735
+105% +$948K 0.41% 76
2021
Q1 		$841K Buy
18,859
+1,363
+8% +$61.9K 0.19% 118
2020
Q4 		$805K Buy
17,496
+790
+5% +$36.3K 0.19% 112
2020
Q3 		$786K Sell
16,706
-522
-3% -$26.2K 0.22% 97
2020
Q2 		$878K Sell
17,228
-46
-0.3% -$2.36K 0.25% 96
2020
Q1 		$818K Buy
17,274
+60
+0.3% +$3.2K 0.27% 90
2019
Q4 		$1.01M Sell
17,214
-90
-0.5% -$5.01K 0.26% 97
2019
Q3 		$923K Buy
17,304
+250
+1% +$12.9K 0.26% 97
2019
Q2 		$853K Buy
17,054
+72
+0.4% +$3.61K 0.24% 101
2019
Q1 		$887K Buy
16,982
+184
+1% +$9.19K 0.25% 98
2018
Q4 		$802K Buy
+16,798
New +$827K 0.26% 95

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cardinal Capital Management Inc (North Carolina)'s GSK Position: Q2 2026 in Review

Cardinal Capital Management Inc (North Carolina) reduced its GSK (GSK) stake by 0.11% in Q2 2026, selling an estimated $3.65K and leaving 62,101 shares worth $3.28M. The position accounts for 0.4% of the portfolio, ranked #79.

Cardinal Capital Management Inc (North Carolina) first reported a position in GSK in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.46M in Q1 2026. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cardinal Capital Management Inc (North Carolina) held 62,101 shares of GSK worth $3.28M as of Q2 2026.
  • Cardinal Capital Management Inc (North Carolina) sold 69 GSK shares in Q2 2026, an estimated $3.65K.
  • GSK made up 0.4% of Cardinal Capital Management Inc (North Carolina)'s portfolio in Q2 2026, its #79 holding.
  • Cardinal Capital Management Inc (North Carolina) first reported a position in GSK in Q4 2018 and has held it in 31 quarters since.
  • Cardinal Capital Management Inc (North Carolina)'s GSK position peaked at $3.46M in Q1 2026.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cardinal Capital Management Inc (North Carolina)'s 13F filing for Q2 2026, filed 21 Jul 2026.